论文部分内容阅读
2007年5月1日,美国制药巨人辉瑞(NYSE:PFE)在美国神经学术年会上宣布,Lyrica作为纤维肌痛综合症(Fibromyalgia)第一个上市治疗药物正在由FDA审批。纤维肌痛综合症是最常
On May 1, 2007, the U.S. pharmaceutical giant Pfizer (NYSE: PFE) announced at the annual meeting of the American Academy of Neurology that Lyrica is under FDA approval as the first marketed treatment for fibromyalgia. Fibromyalgia syndrome is the most common